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The flavivirus nonstructural glycoprotein NS1 is highly conserved and contains two N-linked glycosylation sites which
are both utilized for addition of oligosaccharides during replication in cell culture. NS1 has been shown to contain epitopes
for protective antibodies; however, its roles in virus replication and pathogenesis remain unknown. To study the function
of NS1 during yellow fever virus replication, six mutant viruses which lack either one or both glycosylation sites and another
one containing silent mutations at both sites were generated by site-directed mutagenesis. Mutants lacking the second
glycosylation site and those bearing silent mutations were similar to the parental virus in their cell culture properties.
Ablation of the first or both glycosylation sites generated mutants exhibiting small plaque phenotypes, decreased virus
yields, reduced cytopathic effects, impaired NS1 secretion, and depressed RNA accumulation. In addition, mutants lacking
the first or both glycosylation sites exhibited significant reduction in mouse neurovirulence after intracerebral inoculation.
These defects appear to result from the lack of N-linked glycans rather than the introduction of deleterious amino acid
substitutions or disruption of cis-acting RNA elements important for RNA replication. These results suggest an important
role for NS1 in flavivirus RNA replication and pathogenesis. q 1996 Academic Press, Inc.
INTRODUCTION Wright, 1985), exists as a homodimer, and is present in
cell-associated, cell-surface, and secreted forms (Ma-
The family Flaviviridae includes three genera of enve-
son, 1989; Winkler et al., 1989, 1988). During flavivirus
loped RNA viruses, the flaviviruses, the pestiviruses, and
infections, NS1-specific antibodies with complement-fix-
the hepatitis C viruses (for review, ref. Rice, 1996). Many
ing activity are produced and the secreted form of NS1
of these viruses are pathogenic for man and other verte-
occurs as a soluble complement-fixing antigen (Russell
brates (Monath, 1986). Yellow fever virus (YF) is the proto-
et al., 1980; Schlesinger and Brandriss, 1983; Smith and
type member of the Flavivirus genus and its genome
Wright, 1985). NS1 contains protective epitopes and both
consists of a single, positive-stranded RNA molecule of
active immunization with NS1 and passive immunization
10,862 bases, with a 5* CAP structure and a nonpolyade-
with NS1-specific monoclonal antibodies can protect ani-
nylated 3* terminus (Rice et al., 1986b). The viral RNA
mals against lethal challenge with the homologous flavi-
encodes a polyprotein of over 350 kDa which is pro- virus (Gould et al., 1986; Jacobs et al., 1992, 1994; Schle-
cessed co- and posttranslationally by host and viral pro- singer et al., 1986, 1985, 1993). NS1 is highly conserved
teases to produce the mature structural and nonstructu- with 12 invariant cysteine residues and two potential N-
ral (NS) proteins (Chambers et al., 1990a; Rice and linked glycosylation sites whose positions are conserved
Strauss, 1990). The gene order is 5*-C-prM(M)-E-NS1- for all mosquito-borne flaviviruses. These properties
NS2A-NS2B-NS3-NS4A-2K-NS4B-NS5-3*, where C (cap- have led to the suggestion that NS1 might play a role in
sid), prM(M) (membrane), and E (envelope) represent the virus assembly and/or maturation (Mason, 1989; Rice et
structural proteins or their precursors and NS1 through al., 1986b).
NS5 are NS proteins (Chambers et al., 1989, 1990b; Lin Nascent NS1 is inserted into the endoplasmic reticu-
et al., 1993a; Rice et al., 1986a). lum (ER) via a hydrophobic internal signal sequence lo-
In contrast to nonstructural proteins encoded by other cated near the C terminus of the E protein, followed
RNA viruses, the flavivirus NS1 protein possesses sev- by signalase cleavage at the E/NS1 junction and core
eral interesting and unusual properties (for review, see glycosylation (Falgout et al., 1989). Studies on the cleav-
Chambers et al., 1990a). NS1 is glycosylated (Smith and age of NS1-2A, using recombinant vaccinia and baculovi-
rus expression systems, indicate that the C-terminal 8
residues of NS1 (Chambers et al., 1990b; Falgout et al.,1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (314) 362-1232. 1989; Hori and Lai, 1990) and as few as 26 amino acids
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TABLE 1from the N-terminus of NS2A (Leblois and Young, 1995)
are sufficient for cleavage by an unidentified proteolytic NS1 Mutationsa
activity in the ER lumen (Falgout and Markoff, 1995). Fol-
Mutant Amino acidlowing dimerization (Winkler et al., 1989), NS1 transits
designation changes Nucleotide changesfrom the ER to the Golgi where at least one of the glycans
is modified to a complex form (Despre´s et al., 1991; Fla-
SB — T2842C, A2845C, A2846T, G2847C, C2848A,mand et al., 1992; Jacobs et al., 1992; Mason, 1989; Post T3076C, G3079T, A3082C
et al., 1991; Pryor and Wright, 1994), and the secreted G1a S132A A2846G, G2847C, C2848T
G1b N130A A2840G, A2841Cform of NS1 is released from the cell. Given the absence
G2a T210A A3080G, A3082Cof a C-terminal hydrophobic anchor, the mechanism by
G2b N208A A3074G, A3075Cwhich NS1 associates with the cellular membranes is
G1aG2a S132A, T210A A2846G, G2847C, C2848T, A3080G, A3082Cunknown. G1bG2b N130A, N208A A2840G, A2841C, A3074G, A3075C
Several functions for N-linked glycans have been
a The nomenclature of the NS1 mutants is based on the loss of thesuggested, including protein folding and stability, pro-
first (G1) and/or the second (G2) glycosylation site and on the residuetection against denaturation and proteolysis, modula-
which is substituted in the consensus sequence for N-linked glycosyla-tion of biological activities, and transport through the
tion, N-X-S/T (a and b for S/T and N, respectively). SB indicates the
secretory pathway (Fiedler and Simons, 1995). Al- mutant bearing eight silent mutations, five at the first site and three at
though both N-linked glycosylation sites of NS1 appear the second site.
to be utilized in vivo (Chambers et al., 1990b; Smith
and Wright, 1985), the functional role of these sugars
MATERIALS AND METHODShas not been determined. Tunicamycin treatment of
flavivirus-infected cells (Chambers et al., 1990b; Des-
Cell culture and YF plaque assayspre´s et al., 1991; Mason, 1989; Winkler et al., 1989) or
transiently expressed NS1 (Jacobs et al., 1992) indi- BHK-21 and human SW-13 cells were propagated in
cates that lack of N-glycans impairs NS1 processing a-minimal essential medium (aMEM) supplemented with
and secretion. These results must be interpreted cau- 10% fetal calf serum (FCS). Titers of infectious YF virus
tiously, however, since tunicamycin might also inhibit or RNA transcripts were determined by plaque assay on
glycosylation of cellular proteins which may be in- SW-13 monolayers. Infected or transfected monolayers
volved in NS1 transport. Recent studies using site-di- were overlaid with aMEM containing 2% FCS and 0.9%
rected mutagenesis have provided evidence that gly- agarose (GIBCO BRL). Plaques were visualized after 5
cosylation may be required for proper function of the days by staining with 0.02% neutral red in phosphate-
NS1 protein. For instance, ablation of the first glycosyl- buffered saline (PBS) and, after fixation of the cells with
ation site of NS1 in a chimeric virus, containing the 7% formaldehyde, by removal of the agarose overlay and
prM and E proteins of tick-borne encephalitis virus staining with 1.3% crystal violet in 20% ethanol.
(TBE) and the remaining proteins and RNA elements
of dengue 4 virus (DEN4), resulted in reduced growth Plasmid constructions and site-directed mutagenesis
in vertebrate and mosquito cells and a significant re-
duction in mouse neurovirulence. In contrast, ablation Plasmids were constructed using standard methods
(Ausubel et al., 1993), and mutations at both conservedof the second site of NS1 increased neurovirulence
(Pletnev et al., 1993). Elimination of one or both N- N-linked glycosylation sites were created by oligonucleo-
tide-directed mutagenesis of uridylated phagemid DNAlinked glycosylation sites in transiently expressed
DEN2 NS1 did not abolish dimerization or secretion (Kunkel, 1985; Lin et al., 1993b). The phagemid pH2J1-
NS1/2A was constructed by subcloning the XbaI frag-but lack of the second site reduced dimer stability as
well as secretion (Pryor and Wright, 1994). Although ment of pBLSCIISK-NS1/2A(/) (C.M.R., A. Grakoui, and
R.G., unpublished) containing the NS1/2A region intothese data provide some information on the involve-
ment of the NS1 glycans in maturation of the protein pH2J1 (Hahn et al., 1992). The strand rescued with helper
phage R408 corresponded to the YF plus strand. Engi-and in flavivirus pathogenesis, the precise role of this
protein in replication remains poorly characterized. neered mutations were verified by sequence analysis
and are listed in Table 1. Full-length YF 17D cDNA tem-To study the functional importance of N-linked glyco-
sylation of NS1 in flavivirus replication, we used site- plates were constructed by in vitro ligation of restriction
fragments from pYF5*3*IV and pYFM5.2 or its mutant de-directed mutagenesis to engineer mutants lacking either
one or both YF NS1 glycosylation sites and an additional rivatives (Rice et al., 1989). pYFM5.2 derivatives with mu-
tations at either N-linked glycosylation site were con-mutant containing multiple silent mutations at both sites.
In this report, we have examined the effects of these structed by replacing the corresponding SstI–MluI (G1
site; YF nts 2486–2947) and MluI–KpnI (G2 site; ntsmutations on virus growth, RNA and protein synthesis,
and mouse neurovirulence. 2947–3262) fragments from the clones produced by site-
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Virus stocks and polyethylene glycol (PEG)
concentration
To prepare concentrated virus stocks, subconfluent
monolayers of SW-13 cells (in 150-mm dishes) were in-
fected at a multiplicity of infection (m.o.i.) of 0.04 PFU
(plaque-forming units)/ml with the wild-type parent or its
mutagenized derivatives in aMEM and 2% FCS. After
3–4 days at 377, culture supernatants were harvested,
clarified as above, and precipitated by adjusting the solu-
tion to 8% PEG 6000 (w/v), 120 mM NaCl, 12 mM Tris–
Cl, pH 8.0, 1 mM EDTA, followed by incubation on ice
for 1 hr. Virus was recovered by centrifugation at 9000 g
for 30 min, resuspended in aMEM and 2% FCS, and
stored in aliquots at 0807.
Growth curves
Subconfluent monolayers of SW-13 cells (35-mm
FIG. 1. NS1 glycosylation mutants. The diagram shows the 352- dishes) were infected at a m.o.i. of 5 PFU/cell with PEG-
residue YF NS1 glycoprotein, portions of the adjacent E and NS2A concentrated virus in aMEM and 2% FCS. After 1 hr atproteins, and the positions of the Asn residues (Asn-130 and Asn-
377, the inoculum was removed and the monolayers were208) in the N-linked glycosylation sites (l) mutagenized in this study
washed with prewarmed aMEM and incubated with 2(numbered relative to the NS1 N terminus). Mutant NS1 constructs, as
described in Table 1 and under Materials and Methods, are dia- ml aMEM containing 2% FCS. Differential growth curves
grammed below. were performed by harvesting and replacing the culture
supernatants at 12, 24, 48, or 72 h postinfection (p.i.).
directed mutagenesis (Fig. 1). To generate pYFM5.2 de- Aliquots were stored at 0807 and titers were determined
rivatives with mutations at both sites, the plasmids con- by plaque assay on SW-13 monolayers.
taining the individual G1 and G2 mutations were digested
Preparation of labeled proteinswith ApaI (which cuts in the E coding region; nt 1599)
and MluI (which cuts between the G1 and G2 sites; nt
SW-13 monolayers (35-mm dishes) were infected at a
2947) and the appropriate fragments ligated. For all con-
m.o.i. of 5 PFU/cell with PEG-concentrated virus stocks
structs, the sequence of the entire subcloned fragment
in aMEM and 2% FCS. At 24 hr p.i., cells were incubated
was verified.
for 6 hr at 377 in methionine-free aMEM containing 2%
FCS and 40 mCi/ml of Tran-35S label (ICN). For pulse –In vitro transcription and RNA transfection
chase experiments, cells were labeled at 23 hr p.i. for 1
Five-prime-capped transcripts were synthesized in
hr with methionine-free aMEM containing 2% FCS and
vitro from full-length cDNA templates using SP6 RNA
100 mCi/ml Tran-35S label and either harvested immedi-
polymerase (Rice et al., 1989). Trace quantities of [a-
ately or incubated for an additional 6 hr in aMEM con-32P]CTP were included in the transcription reactions to
taining 2% FCS and 10 times the normal amount of unla-
permit quantitation of RNA yield and analysis of transcript
beled methionine. At the desired intervals, supernatants
integrity. Incorporation was measured by adsorption to
were collected and clarified at 3000 g for 2 min and
DE81 (Whatman) filter paper (Sambrook et al., 1989). Sub-
cells were lysed in either SDS- or Triton X-100 (Triton)-
confluent BHK monolayers (35-mm dishes) were used for
containing lysis solution, as described previously (Cham-
RNA transfection with lipofectin (GIBCO BRL; Rice et al.,
bers et al., 1989).
1989). Transfection mixtures were made by mixing 100
ng of RNA with 200 ml of PBS containing 8 mg of lipofectin Immunoprecipitation
followed by incubation on ice for 10 min. During this time,
monolayers were washed twice with PBS. The mixtures SDS-treated viral proteins were immunoprecipitated
using NS1-specific polyclonal (Chambers et al., 1990b)were added to the cells and incubated at room tempera-
ture for 10 min. Following transfection, monolayers were or monoclonal antibodies 8G4 and 1A5 (Schlesinger and
Brandriss, 1983). Triton-solubilized proteins were immu-washed once with aMEM and either incubated in aMEM
containing 2% FCS at 377 to generate virus stocks or noprecipitated by a YF-specific mouse hyperimmune as-
citic fluid (HIAF; kindly provided by Joel Dalrymple) orassayed directly for plaque formation. For virus stocks,
cell culture supernatants were harvested at 3–4 days monoclonal antibodies 5H3 (anti-E; Schlesinger et al.,
1983) or 8G4, as previously described (Chambers et al.,posttransfection and clarified at 3000 g for 10 min, and
aliquots stored at 0807. 1990b). All immunoprecipitates were collected using
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Staphylococcus aureus Cowan strain I (Calbiochem) and SP6 RNA promoter of positive-sense or negative-sense
RNA probes of 284 nucleotides.analyzed by sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS–PAGE) (Chambers et al., 1990b;
Animal experimentsLaemmli, 1970). Gels were treated with 1 M sodium sali-
Four-week-old female mice (ICR strain; Harlancylate, pH 7.0, for fluorographic detection of radiolabeled
Sprague–Dawley) were used for mouse neurovirulenceproteins at 0807 (Chamberlain, 1979).
studies. All animal handling was conducted according to
approved standards for the care and use of laboratoryEndoglycosidase digestion
animals. Mice were anesthetized with methoxyfluorane
and injected in the left frontal cortex with approximatelyS. aureus pellets containing immunoprecipitated YF
5000 PFU of the parental virus or G1b, G2b, or G1bG2bNS1 proteins were solubilized and digested with either
NS1 mutants in 30 ml of pyrogen-free PBS (GIBCO BRL).endoglycosidase H (Endo H) or glycopeptidase F
This dose was selected because a similar dose of the(PNGase F) (Boehringer Mannheim) or were incubated
parent virus (YFiv5.2) (Rice et al., 1989) has been ob-without added endoglycosidase using conditions de-
served to cause nearly uniform mortality in young adultscribed by Mason (1989). After incubation, samples were
CD-1 mice (Schlesinger et al., 1996). Actual titers of infec-analyzed by SDS–PAGE as described above.
tious virus in each inoculum were determined by plaque
assay on SW-13 cells at the time of inoculation. MiceRNA analysis
were observed until found dead or sacrificed when found
in an advanced moribund condition. When possible, seraSW-13 monolayers (35-mm dishes) were infected at a
were collected and stored at 0807 until use for determi-m.o.i. of 5 PFU/cell with PEG-concentrated viruses in
nation of plaque reduction neutralization titers.aMEM and 2% FCS. At 4, 12, 24, and 36 h p.i. cells were
washed once with ice-cold PBS and total cellular RNA
Neutralization titerswas isolated by using the RNAzol method (TEL-TEST,
Virus neutralization titers were measured by plaqueInc.). The RNase protection assay for analysis of positive-
reduction neutralization assays using the parent as aand negative-strand RNAs was performed essentially as
test virus and SW-13 cells to monitor plaque formation.described by Novak and Kirkegaard (1991). For positive-
Mouse sera were collected upon sacrifice or between 3strand analysis, 5 mg total cytoplasmic RNA was resus-
and 6 weeks following infection, for mice which survived.pended in 30 ml hybridization buffer containing 1.5 pmol
Briefly, 20 ml of sera was heat-inactivated and dilutedof 35S-labeled (or 32P-labeled) RNA probe (see below)
serially in minimal essential media containing 2% FCS.followed by denaturation at 857 for 5 min, hybridization
These dilutions were mixed with 200 PFU virus and incu-overnight at 557, and treatment with RNases A and T1.
bated for 6 hr at 47 prior to plaque assay. The neutraliza-Negative-strand RNAs were analyzed using a two-cycle
tion titer is given as the highest serum dilution capable ofRNase protection assay (Novak and Kirkegaard, 1991).
neutralizing 50% of the input virus compared to samplesFive micrograms of total cytoplasmic RNAs were resus-
containing no mouse serum.pended in 30 ml of hybridization buffer and hybridized
overnight at 557 in the presence of 10 ng of RNA tran-
RESULTSscribed from pTM3/YF/NS3 which had been linearized
with XhoI (Chambers et al., 1993). After RNase treatment Oligonucleotide-directed mutagenesis of both con-
and alcohol precipitation, the samples were resus- served N-linked glycosylation sites (Asn-130 and Asn-
pended in 30 ml of hybridization buffer containing 1.5 208) was used to probe the function of NS1 glycosylation
pmol of 35S-labeled RNA probe (see below), denatured in YF replication. Mutations were introduced to abolish
at 857 for 5 min, hybridized overnight at 557, and digested glycosylation at the first (G1), the second (G2), or both
with RNases. Protected fragments were separated by (G1G2) N-linked glycosylation sites by replacement of
electrophoresis in 5% polyacrylamide–urea sequencing the Asn (series b) or Ser/Thr (series a) residues with Ala
gels which were fixed, dried, and subjected to autoradi- residues (Table 1 and Fig. 1). To control for the possibility
ography (Sambrook et al., 1989). that cis RNA elements important for replication might be
35S-labeled (or in some cases 32P-labeled) RNA probes located in these regions of the YF genome, we created
were synthesized by in vitro transcription of pProteus31/ an additional mutant (SB) with eight silent mutations, five
5.23839–4089 (positive-sense probe) or pProteus31/5.24089–3839 at the first glycosylation site and three at the second
(negative-sense probe) (as described in the Promega Proto- (Table 1).
cols and Applications Guide). These plasmids were con-
Recovery of NS1 mutant viruses after RNAstructed by subcloning the BglII (3839)–BamHI (4089) frag-
transfectionment of pYFM 5.2 (Rice et al., 1989) into BglII-digested
pProteus 31 (kindly provided by H. V. Huang). Plasmids As shown in Table 2, RNA transcripts derived from
the parent and mutant templates had similar specificwere linearized with AccI to allow transcription from the
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TABLE 2 mutants (100-fold), particularly at early time points
(data not shown).Effects of Mutations on Viral Replicationa
RNA-specific Virus Analysis of proteins in infected cells
infectivityb (PFU/ yieldc
Virus 20 ng RNA) (PFU/ml) Plaque sized To characterize the virus-specific proteins produced
by these mutants, lysates of metabolically labeled mock-
Wild type 25 1.3 1 107 L
and virus-infected SW-13 cells were immunoprecipitatedSB 31 1.0 1 107 L
with a polyclonal YF-specific mouse antiserum (HIAF;G1a 33 6.5 1 105 S
G1b 30 2.0 1 105 S Fig. 3). As predicted for mutations ablating one or both
G2a 38 9.5 1 106 M glycan acceptor sites, forms of NS1 with faster mobilities
G2b 32 1.0 1 107 M were observed for the single and the double mutants
G1aG2a 35 6.0 1 105 T
(1 and 2 kDa increase in mobility, respectively). TheG1bG2b 30 1.3 1 105 T
latter form of NS1 comigrated with the NS1 produced in
a BHK-21 cells were transfected with RNA transcripts as described YF-infected cells labeled in the presence of tunicamycin.
under Materials and Methods. For the G1 mutants, NS1 migrated slightly faster than
b Number of plaques obtained at 5 days posttransfection with 20 ng the form produced by the G2 mutants (see below). As
of RNA.
expected, silent mutations in the NS1 coding region ofc Viral titer in the media harvested from the monolayers at 72 hr post
SB did not alter the apparent MW of NS1 by SDS–PAGE.RNA transfection. Titers were determined by plaque assay on SW-13
cells. The profiles of the other viral proteins were similar, al-
d Relative plaque size at 5 days posttransfection. L, large; M, medium; though a slight decrease in virus-specific protein synthe-
S, small; T, tiny. sis was observed for G1a, G1b, G1aG2a, and G1bG2b
(Fig. 3).
The nature of the N-linked oligosaccharides at the G1infectivities and produced viable virus after RNA transfec-
and G2 acceptor sites was determined by endoglycosi-tion of SW-13 monolayers. These results show that NS1
dase digestion (Fig. 4). Cell-associated and secretedglycosylation is not required for the initiation of YF RNA
replication. Virus yields and plaque sizes, however, dif-
fered considerably for some of the mutants. The SB mu-
tant containing the eight silent nucleotide substitutions
was phenotypically identical to the parental virus (Table
2). G2a and G2b produced similar virus yields compared
to the parent but exhibited slightly smaller plaques. In
contrast, mutants lacking either the first site (G1a and
G1b) or both glycosylation sites (G1aG2a and G1bG2b)
produced depressed virus yields (20- to 100-fold less)
and small plaques compared to the parent.
Growth properties
The NS1 mutants and parental virus were compared
for growth rate and yield after high multiplicity infection
of SW-13 cells (Fig. 2). Similar to the parental virus, all
of the mutants produced the highest yields between 24
and 48 hr p.i. However, the mutants lacking both glycosyl-
ation sites produced reduced yields (10- to 20-fold) dur-
ing the first 24 hr. Cytopathic effects (CPE), which be-
came pronounced between 24 and 48 hr, were similar
in infections with the parental virus, SB, G2a, and G2b.
Interestingly, in cells infected with mutants lacking the
first or both glycans (G1a, G1b, G1aG2a, and G1bG2b),
relatively high virus yields were still being produced be-
FIG. 2. Single-step growth analyses. Subconfluent monolayers oftween 48 and 72 hr p.i. (Fig. 2) and significant CPE was
SW-13 cells were infected at a m.o.i. of 5 PFU/cell with either the wild-observed only after 72 hr. Similar results were obtained
type virus (wt) or the indicated NS1 mutant viruses. At 12, 24, 48, and
after infection at lower multiplicities (0.5 PFU/cell) except 72 hr p.i. the medium was collected and replaced with fresh medium.
that the yields of the G1 and G1G2 mutants were more Titers of virus recovered from the media over these intervals were
determined by plaque assay on SW-13 cells.dramatically reduced compared to the parent and other
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FIG. 3. Immunoprecipitation of metabolically labeled viral proteins.
SW-13 cells were mock-infected or infected at a m.o.i. of 5 PFU/cell
with either the wild-type virus (wt) or the indicated NS1 mutants. At 24
hr p.i., cells were labeled with [35S]methionine for 6 hr, in the presence
or absence of 5 mg/ml of tunicamycin (tun), and then disrupted with
lysis buffer. Lysates were immunoprecipitated with YF-specific mouse
HIAF and analyzed by SDS–13% PAGE as described under Materials
and Methods. The positions of molecular weight markers are indicated
on the left (in kDa) and YF-specific proteins on the right.
FIG. 5. Pulse–chase analysis of YF glycoprotein processing and
secretion. Duplicate SW-13 cell cultures were mock-infected or infectedforms of NS1 were immunoprecipitated and treated with
with either the wild type virus (wt) or the indicated NS1 mutants at aEndo H, which removes high-mannose N-linked glycans,
m.o.i. of 5 PFU/cell. At 23 hr p.i., cells were pulse-labeled with [35S]-or PNGase F, which cleaves both high mannose and
methionine for 1 hr. One set of samples was harvested immediately
complex chains. NS1 from cell lysates was sensitive to following the pulse (p). For the remaining cultures, the labeling medium
digestion with either endoglycosidase (Fig. 4A), demon- was replaced with aMEM containing 10 times the normal amount of
unlabeled methionine and chased for a period of 6 hr (c). (A) NS1 orstrating that cell-associated NS1 possesses predomi-
(B) E were immunoprecipitated from cell extracts (top gel in each part)nantly high-mannose oligosaccharide chains, as noted
or cell culture supernatants (bottom gel in each part) and analyzed bypreviously (Despre´s et al., 1991; Jacobs et al., 1992; Ma-
SDS–10% PAGE as described under Materials and Methods. A mixture
son, 1989; Post et al., 1991; Pryor and Wright, 1994; Wink- of monoclonal antibodies 8G4 and 1A5 was used to immunoprecipitate
ler et al., 1988). NS1 secreted by the G1 mutants was NS1; monoclonal 5H3 was used to immunoprecipitate E.
completely Endo H-sensitive, whereas that secreted by
the G2 mutants was Endo H-resistant (Fig. 4B). This indi-
cates that glycans linked to Asn-130 (G1) are of the com- by the parental virus and the SB mutant (Fig. 4B), and
plex type and those linked to Asn-208 (G2) are simple parallel previous findings for DEN2 NS1 (Pryor and
high-mannose chains. These results are consistent with Wright, 1994).
the partial Endo H sensitivity observed for NS1 secreted The importance of NS1 glycans for proper processing,
stability, and secretion was examined in pulse–chase
experiments (Fig. 5A). After a 1-hr pulse, similar levels
of mature NS1, as well as higher molecular weight forms,
were detected in cells infected with the parent and the
mutant viruses (Fig. 5A, top). It has been previously sug-
gested that these high molecular weight proteins repre-
sent polyprotein precursors consisting of NS1 and a por-
tion of the NS2A protein (Chambers et al., 1990b). After
a 6-hr chase, the NS1-2A polyprotein had disappeared
and only mature NS1 was detectable in cell lysates in-
fected with the parent or any of the mutants (Fig. 5A,
top). In the cell culture media, similar levels of NS1 had
been secreted from cells infected with the parental virus,FIG. 4. Endoglycosidase analyses of NS1. SW-13 cells were infected
and labeled as described for Fig. 3. Following labeling and treatment SB, G2a, and G2b (Fig. 5A, bottom). In contrast, removal
with Triton, (A) cell-associated and (B) secreted NS1 were immunopre- of the first (G1a, G1b) or both (G1aG2a, G1bG2b) glyco-
cipitated using the 8G4 NS1-specific monoclonal antibody. Solubilized
sylation sites dramatically reduced NS1 secretion. Noimmunoprecipitates were treated with Endo H (H) or PNGase F (F) or
major effect was observed on the appearance of E in thewere incubated without added endoglycosidase (0), and analyzed by
SDS –10% PAGE. culture media (Fig. 5B), suggesting that impaired NS1
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FIG. 6. Accumulation of YF-specific positive- and negative-strand RNAs. SW-13 cells were mock-infected or infected at a m.o.i. of 5 PFU/cell with
the wild-type virus (wt) or the NS1 mutants. At 4, 12, 24, and 36 hr, total cytoplasmic RNAs were isolated and the levels of YF-specific RNAs
determined using RNase protection as described under Material and Methods. (A and B) Positive- and negative-strand analyses, respectively. The
autoradiogram shown in A was exposed for 1 hr, whereas that shown in B was exposed for 48 hr. The sizes of the probe and protected fragments
are 284 and 251 nt, respectively. Similar results have been obtained in four independent experiments.
secretion may not influence the production of mature m.o.i. growth experiments indicate that the lack of a gly-
can at the first NS1 glycosylation site is associated withvirions or subviral particles (see Discussion).
a reduced rate of RNA accumulation and a delay in pro-
duction of infectious virus.RNA accumulation in infected cells
The small plaque phenotype and slow growth of the Mouse neurovirulence
G1 and G1G2 mutants in high m.o.i. infections indicated
A subset of the NS1 mutants was examined in a mousea possible early defect in replication perhaps at the level
neurovirulence assay. Given that no differences wereof viral RNA synthesis. To investigate this hypothesis,
observed in the cell culture phenotypes of the a and bSW-13 cells were mock-infected or infected at a high
series mutants, animal experiments were performed us-m.o.i. (5 PFU/cell) with the wild type or the NS1 mutants.
ing only G1b, G2b, G1bG2b, and the parent. Table 3At 4, 12, 24, and 36 hr after infection, positive- and nega-
summarizes the mortality endpoints for the parental virustive-strand RNA viral accumulation was analyzed by
RNase protection (Fig. 6). Note that a background band
present in the mock-infected sample in the negative- TABLE 3
strand analysis does not allow a clear assessment of
Mouse Neurovirulence of NS1 Mutantsathe levels of virus-specific negative-strand RNA accumu-
lated at the early time points (4 and 12 hr). SB, G2a, Mouse survival
and G2b exhibited levels of positive- and negative-strand Virus (survived/inoculated) P valueb
RNA accumulation similar to the wild-type virus (Figs. 6A
Wild type 3/12 —and 6B). During infections with G1a, G1b, and the G1G2
G1b 10/12 0.005double mutants, positive- and negative-strand RNA accu-
G2b 4/13 NS
mulation was diminished relative to the parent up to 24 G1bG2b 13/13 0.002
hr, but approached wild-type levels by 36 hr. These ex-
a Four-week-old female ICR mice were inoculated intracerebrallyperiments were also performed at low m.o.i. (0.5 PFU/
with 5000 PFU of wild-type virus or each of the NS1 mutants. Mice werecell) with similar results except that the reduction in the
observed daily until found dead or sacrificed when found in advancedlevels of positive- and negative-strand RNA accumulation
moribund condition.
were more pronounced (approx fivefold lower for the G1 b P value refers to the significance of the proportion of mice surviving
and G1G2 mutants; data not shown). The results of these in each group compared with the wild-type group. Statistical signifi-
cance was evaluated by x2 analysis. NS, not significant.RNA analyses together with those obtained for the high
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and the three NS1 glycosylation mutants. All mice which and (ii) the SB mutant, containing a total of eight silent
substitutions at the two N-linked sites, was phenotypi-died during the experiment exhibited typical signs of en-
cephalitis. Surviving mice were observed for a total of 6 cally identical to the wild-type parent. Rather, the differ-
ences in RNA accumulation and virulence more likelyweeks. The parent caused 75% mortality, with the mean
time to death of approximately 10.5 days. Among the result from altered function of the mutant NS1 proteins.
Moreover, mutants in which different amino acid substi-survivors, two-thirds exhibited signs of illness (ruffling
or hindlimb weakness) during the observation period. tutions were used to disrupt the same glycosylation
site(s) exhibited similar phenotypes. This suggests thatMortality in the G2b group (9/13 mice) and mean time to
death (11.7 days) were similar to those of the parental the observed differences in RNA replication and neurovi-
rulence result from the lack of N-linked glycans rathervirus. All survivors in the G2b group exhibited moderate
signs of illness during the observation period. Sixteen than substitution of alanine for asparagine or serine/thre-
onine in the consensus sequence.percent mortality was observed for the G1b group, with
two deaths occurring only after 16 days, and most survi- Given that NS1 is glycosylated and secreted, it was
previously thought to have a role in virus assembly and/vors exhibiting only mild signs of illness. No deaths oc-
curred among the mice infected with the G1bG2b mutant, or release. Thus far, no compelling evidence exists to
support this notion. The E protein, which is secreted asand minimal signs of disease were observed in this
group. Pairwise comparisons of the proportions of mice mature virus or in subviral particles, is readily released
from infected mosquito cells which do not secrete NS1surviving infection with each mutant relative to the paren-
tal virus were made using x2 analysis. A statistically (Mason, 1989). In addition, mutations which impair NS1
secretion do not affect release of E (this study). Rather,significant difference was not observed between the par-
ent and the G2b mutant (P  0.1). Significant differences our results suggest that NS1 may participate in viral RNA
replication. Flavivirus RNA amplification is believed towere observed, however, between the parent and G1b
(P  0.005) or G1bG2b (P  0.002). occur at sites in the perinuclear reticular network (Brin-
ton, 1986; Westaway, 1987) where the putative replicaseTo verify that infection had indeed occurred, antibody
responses were determined where possible for most of components (such as the NS3 RNA helicase and NS5
RNA-dependent RNA polymerase) are believed to bethe mice in each group (9/12 for the parental virus, 6/13
for the G2b group, 10/12 for G1b, and 12/13 for G1bG2b). membrane-associated (Wengler et al., 1990). Flavivirus
infection results in marked hypertrophy of subcellularTiters among the groups were as follows (reciprocal of
the 50% plaque reduction titer): parental virus, range40 membrane organelles, producing vesicles which may ac-
tually represent sites of RNA replication (Brinton, 1986;to 1280, median of 320; G2b, range 640 to2560, median
of 1280; G1b, range 40 to 1280, median of 640; Murphy, 1980; Westaway, 1987). How NS1 might partici-
pate in RNA replication is unclear. The lumenal ratherG1bG2b, range 40 to 2560, median of 320 (data not
shown). than cytoplasmic localization of the NS1 glycoprotein
makes it unlikely that the mature cleavage product func-
tions as an enzymatic component. We have observed byDISCUSSION
immunofluorescence that NS1 is localized in the perinu-
clear region (data not shown), which suggests that itThis mutagenesis study has provided new insight into
the function of the NS1 glycoprotein in flavivirus replica- could be involved in the reorganization of cellular mem-
branes to allow formation of active replication com-tion and pathogenesis. YF 17D mutants lacking the sec-
ond NS1 glycosylation site or bearing multiple silent nu- plexes. Alternatively, NS1 could function as a replicase
component but perhaps as part of an uncleaved polypro-cleotide substitutions were phenotypically similar to the
parental virus. In contrast, mutants lacking the first or tein, or indirectly through continued interaction with
NS2A after cleavage at the NS1/2A site. Further studiesboth N-linked glycans produced small plaques, delayed
CPE, depressed virus yields, impaired NS1 secretion, are needed to understand the mechanism by which NS1
influences the efficiency of RNA replication.and deficient RNA accumulation. None of the mutants
exhibited an obvious defect in either polyprotein pro- Results of the mouse inoculation experiments indicate
that the G1b and G1bG2b mutants are attenuated in neu-cessing or E protein secretion. In addition, mutants lack-
ing the first glycosylation site were attenuated in a mouse rovirulence when compared with the parental virus or
G2b. The observed effects of these mutations on neurovi-neurovirulence model. These results suggest that proper
glycosylation of NS1 is important for an early function rulence are unlikely to be caused by either differences
in challenge inoculum, since equivalent doses of eachwhich can influence the efficiency of viral RNA replication
which may be related to the pathogenesis of the virus. virus were verified by plaque assay, or failure to initiate
infection, since significant levels of neutralizing antibod-The possibility that these defects are mediated directly
at the RNA level, via changes in the RNA structure or ies were generated in each group of mice. We believe
that the differences in mortality associated with the G1bstability, seems unlikely since (i) the mutant and parental
RNA transcripts exhibited similar specific infectivities and G1bG2b YF mutants are likely to reflect true quantita-
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